Baird Initiates Coverage On Immutep with Outperform Rating, Announces Price Target of $7
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Joel Beatty has initiated coverage on Immutep (NASDAQ:IMMP) with an Outperform rating and a price target of $7.
August 04, 2023 | 12:34 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Immutep has received an Outperform rating from Baird with a price target of $7.
The Outperform rating from Baird indicates a positive outlook for Immutep. The price target of $7 suggests a potential upside for the stock. This could lead to increased investor interest and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100